MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aerin Medical Inc., a company dedicated to providing Ear, Nose and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal ...

The perennial allergic rhinitis market is projected to progress steadily, supported by a relatively small but focused pipeline of emerging therapies. Companies developing candidates such as EBGLYSS ...

Patients with moderate to severe allergic rhinitis (AR) often experience years of uncontrolled symptoms, worsened quality of ...

GALWAY, Ireland--(BUSINESS WIRE)--Neurent Medical, a company pioneering innovative treatments for chronic inflammatory sino-nasal diseases, today announced it has closed a $25 million Series B ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients with chronic rhinitis who had ...

The Cigna Group CI recently announced that it will start covering RhinAer, a minimally invasive solution for chronic rhinitis, starting Sept. 15, 2025. This move highlights the increasing confidence ...

An update of recommendations for the treatment of seasonal allergic rhinitis (SAR) in adolescents and adults, issued by members of the Joint Task Force on Practice Parameters (JTFPP), changes initial ...

Objective: Corticosteroids are effective in controlling the inflammatory component of allergic rhinitis; however, evidence for the clinical efficacy of systemic corticosteroids in this disease is ...

The incidence of provider-diagnosed AR in the United States is approximately 60 million people, including both adults and children. 2 The incidence is even higher when patients self-report AR: between ...

Biopharmaceutical company Allovate has signed an agreement with personalized medicine firm Restore Health for the exclusive rights to provide Allerdent, a new therapeutic toothpaste delivery system ...

Dr Deepti Sinha, Lead Consultant, Dept of ENT at CK Birla Hospital, highlights the nose’s role as a gateway for inhaled air, ...

Adults with allergic rhinitis experience diagnostic delays and limited access to allergen immunotherapy, impacting quality of life and treatment satisfaction. ICE activity in Minnesota healthcare ...